Global PSA Test Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 CLIA
- 1.2.1.2 ELISA
- 1.2.1.3 Others
- 1.2.2 by Application
- 1.2.2.1 Screening
- 1.2.2.2 Post-treatment Monitoring
- 1.2.2.3 Others
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 CLIA Market, 2013-2018
- 4.1.2 ELISA Market, 2013-2018
- 4.1.3 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 CLIA Market Forecast, 2019-2024
- 4.2.2 ELISA Market Forecast, 2019-2024
- 4.2.3 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Screening Market, 2013-2018
- 5.1.2 Post-treatment Monitoring Market, 2013-2018
- 5.1.3 Others Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Screening Market Forecast, 2019-2024
- 5.2.2 Post-treatment Monitoring Market Forecast, 2019-2024
- 5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Abbott
- 8.2 Siemens Healthcare
- 8.3 DiaSorin
- 8.4 Roche
- 8.5 Beckman Coulter
- 8.6 PerkinElmer
- 8.7 Tosoh
- 8.8 Ortho Clinical
- 8.9 Fujirebio
- 8.10 Mediwatch
- 8.11 BodiTech
9 Conclusion
Summary
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood
The global PSA Test market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
CLIA
ELISA
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Screening
Post-treatment Monitoring
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa